COVID-19 information and resources for the public on precautions to avoid illness, vaccines, symptoms, testing, treatments, and therapeutics.
Precautions to Avoid Illness
- Vaccines for COVID-19 (CDC)
- Stay Up to Date with COVID-19 Vaccines (CDC)
- COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised (CDC)
- Frequently Asked Questions about COVID-19 Vaccination (CDC)
- Find a Vaccine (CDC)
- To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233.
- Safety & Monitoring (CDC)
- Protect Yourself and Others (CDC)
- Getting Tested for COVID-19 If Needed (CDC)
- Following Recommendations for What to Do If You Have Been Exposed (CDC)
- Staying Home If You Have Suspected or Confirmed COVID-19 (CDC)
- Avoiding Contact with People Who Have Suspected or Confirmed COVID-19 (CDC)
- Travel Health
If you have COVID-19, you can spread the virus to others. Isolation and avoiding contact with people who are at high risk of getting very sick can help prevent others from getting sick.
- What to Do If You Were Exposed to COVID-19 (CDC)
- Isolation and Precautions for People with COVID-19 (CDC) - The isolation and Exposure Calculator is available at this link as well as information on when and how long to isolate.
- Testing Guidance (CDC)
- Self-Testing (CDC)
- COVID-19 Testing Resources (CDC)
- Multi-Language Testing Resources - translated instructions for at-home tests, conversation guides, fact sheets, and more. (NRC-RIM)
- Find Federally Qualified Health Centers in South Dakota - community-based primary care services in underserved areas providing care on a sliding fee scale based on ability to pay.
Treatments and Therapeutics
- The COVID-19 Test To Treat Initiative quickly connects eligible individuals who are at high risk of getting very sick from COVID-19 to appropriate treatments.
- COVID-19 Treatments and Therapeutics (HHS)
- COVID-19 Treatments and Medications (CDC)
- Evusheld is an investigational medicine that can help protect you from getting COVID-19. You may be eligible for Evusheld if you:
- Are moderately or severely immunocompromised and may not mount an adequate immune response to COVID-19 vaccination OR have a history of severe allergic reactions to COVID-19 vaccines, and
- Do not currently have COVID-19 and have not recently had close contact with someone with COVID-19, and
- Are an adult or adolescent ages 12 years and older weighing at least 88 pounds (40 kg).
- Know Your Treatment Options for COVID-19 (FDA)
- Treatment Locator (HHS)
The U.S. Food and Drug Administration issued an Emergency Use Authorization to allow the use of monoclonal antibodies for the treatment of mild to moderate symptoms of COVID-19 in adults and pediatric patients.
What are monoclonal antibodies? Monoclonal antibodies are laboratory-made proteins that mimic the antibodies created by your immune system to fight off harmful viruses. Bamlanivimab + etesevimab and casirivimab + imdevimab are monoclonal antibodies that are specifically designed to protect against severe COVID-19 infection. The antibodies bind to the spike protein of the COVID-19 virus to stop the virus from entering your cells and continuing the infection.
- Who can get this treatment? Antibody treatment can be used by people with mild to moderate COVID-19 who:
- Test positive for SARS-CoV-2;
- Are within 10 days of the start of their symptoms;
- Are age 12 or older and weigh at least 88 pounds; and
- Are at high risk of progressing to severe COVID-19 infection or of needing to be admitted to a hospital because of COVID-19. Examples of chronic medical conditions include:
- Chronic kidney disease
- Immunosuppressive disease
- Currently receiving immunosuppressive treatment
- Having a body mass index (BMI) greater than 25 (overweight or obese)
- Aged 65 years and older
- Cardiovascular disease (including congenital heart disease) or hypertension
- Chronic lung diseases (e.g., chronic obstructive pulmonary disease [COPD], asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis, and pulmonary hypertension)
- Sickle cell disease
- Neurodevelopmental disorders (e.g., cerebral palsy) or other complex conditions (e.g., genetic or metabolic syndromes and severe congenital abnormalities)
- Having a medical-related technological dependence (e.g, tracheostomy, gastrostomy, or positive pressure ventilation [not related to COVID-19])
Individuals who meet high-risk criteria and test positive should contact their primary care physician about a referral for antibody treatment within three days of a positive test result and no later than 10 days after symptom onset.
Treatment for COVID-19 is available in many parts of the state. Check with your healthcare provider about the use of monoclonal antibodies or an antiviral.